Issued Share Capital and Other Reserves - Additional Information (Details)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
14 Months Ended |
|
|
|
|
|
|
Oct. 17, 2019
shares
|
Oct. 04, 2019
EUR (€)
shares
|
Jul. 01, 2019
EUR (€)
shares
|
Jul. 01, 2019
$ / shares
|
Nov. 05, 2018
EUR (€)
shares
|
Nov. 05, 2018
USD ($)
shares
|
Apr. 03, 2018
EUR (€)
|
Feb. 16, 2018
Beneficiary_Certificate
|
Dec. 29, 2017
USD ($)
shares
|
Dec. 15, 2017
USD ($)
|
Jul. 13, 2017
EUR (€)
shares
|
Jul. 13, 2017
$ / shares
|
Oct. 17, 2016
EUR (€)
shares
|
Oct. 17, 2016
$ / shares
|
Jan. 17, 2014
EUR (€)
shares
|
Dec. 19, 2013
EUR (€)
shares
|
Nov. 13, 2012
EUR (€)
shares
|
Jan. 31, 2018
USD ($)
shares
|
Dec. 31, 2013
EUR (€)
|
Dec. 31, 2012
EUR (€)
|
Dec. 31, 2019
EUR (€)
Beneficiary_Certificate
€ / shares
shares
|
Dec. 31, 2018
EUR (€)
Beneficiary_Certificate
€ / shares
shares
|
Dec. 31, 2017
EUR (€)
€ / shares
shares
|
Dec. 31, 2019
EUR (€)
Beneficiary_Certificate
€ / shares
shares
|
Dec. 31, 2019
USD ($)
Beneficiary_Certificate
shares
|
Mar. 07, 2018
shares
|
Jan. 01, 2018
shares
|
Dec. 15, 2017
EUR (€)
shares
|
Nov. 20, 2013
shares
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Authorized and subscribed shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
403,032,520
|
403,032,520
|
403,001,760
|
403,032,520
|
403,032,520
|
|
|
|
|
| Authorized and subscribed shares, par value | € / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0.000625
|
€ 0.000625
|
€ 0.000625
|
€ 0.000625
|
|
|
|
|
|
| Ordinary shares issued |
1,991,627
|
1,600,000
|
|
|
|
|
|
|
1,754,960
|
|
|
|
|
|
|
|
4,204,120
|
9,431,960
|
|
|
|
|
|
|
|
|
9,431,960
|
4,800,000
|
8,233,160
|
| Gross proceeds from issuance of ordinary shares | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 79,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Transaction costs incurred | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Contingent options recognized as derivative liability | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 31,000,000
|
€ 39,000,000
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised |
|
1,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants effectively net settled |
3,520,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants | € |
|
€ 74,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 74,000,000
|
€ 0
|
€ 0
|
|
|
|
|
|
|
| Long term investments | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 1,497,000,000
|
€ 1,646,000,000
|
|
€ 1,497,000,000
|
|
|
|
|
|
| Convertible notes exchanged principal amount | $ |
|
|
|
|
|
|
|
|
$ 110,000,000
|
$ 301,000,000
|
|
|
|
|
|
|
|
$ 628,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Number of beneficiary certificates issued per share | Beneficiary_Certificate |
|
|
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible notes | € |
|
|
|
|
|
|
€ 1,100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares authorized to be repurchased |
|
|
|
|
10,000,000
|
10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares repurchased |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,679,156
|
6,427,271
|
|
|
|
|
|
|
|
| Share repurchase program expiry date |
|
|
|
|
Apr. 21, 2021
|
Apr. 21, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Apr. 21, 2021
|
|
|
|
|
|
|
|
| Warrants expiry date |
|
|
Jul. 01, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dividends recognised as distributions to owners | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 0
|
|
|
|
|
|
|
|
|
| Number of treasury shares reissued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,557,405
|
3,382,312
|
|
|
|
|
|
|
|
| Number of ordinary shares held as treasury shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,166,710
|
3,044,959
|
|
3,166,710
|
3,166,710
|
|
|
|
|
| Number of beneficiary certificates held by founders | Beneficiary_Certificate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
378,201,910
|
364,785,640
|
|
378,201,910
|
378,201,910
|
|
|
|
|
| November 5, 2018 Program |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares repurchased |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,366,427
|
|
|
|
|
|
| Approved share repurchase amount | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 510,000,000
|
|
|
|
|
|
| Top of Range |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares authorized to be repurchased |
|
|
|
|
10,000,000
|
10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Approved share repurchase amount |
|
|
|
|
€ 1,000,000,000
|
$ 1,000,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Spotify Netherlands B.V. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,740,000
|
|
|
|
| Certain Members of Key Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
1,991,627
|
1,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from warrants issued | € |
|
|
€ 15,000,000
|
|
|
|
|
|
|
|
|
|
€ 27,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares that can be acquired from warrants issued |
|
|
800,000
|
|
|
|
|
|
|
|
|
|
5,120,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of each warrant | $ / shares |
|
|
|
$ 190.09
|
|
|
|
|
|
|
|
|
|
$ 50.61
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of each warrant to fair market value of ordinary shares on date of issuance |
|
|
130.00%
|
|
|
|
|
|
|
|
|
|
120.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised |
|
1,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants effectively net settled |
3,520,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants | € |
|
€ 74,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expiry date |
|
|
Jul. 01, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee and Member of Management of Group |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from warrants issued | € |
|
|
€ 15,000,000
|
|
|
|
|
|
|
|
€ 9,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares that can be acquired from warrants issued |
|
|
800,000
|
|
|
|
|
|
|
|
1,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of each warrant | $ / shares |
|
|
|
$ 190.09
|
|
|
|
|
|
|
|
$ 89.73
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of each warrant to fair market value of ordinary shares on date of issuance |
|
|
130.00%
|
|
|
|
|
|
|
|
130.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expiry |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020-07
|
|
|
|
|
|
|
|
|
| Warrants expiry date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jul. 01, 2022
|
|
|
|
|
|
|
|
|
| TME |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,552,440
|
|
| Long term investments | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 1,481,000,000
|
€ 1,630,000,000
|
€ 910,000,000
|
€ 1,481,000,000
|
|
|
|
€ 910,000,000
|
|
| Transfer restrictions period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
| First Closing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,584,160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance of ordinary shares | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 123,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Transaction costs incurred | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Second Closing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,649,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance of ordinary shares | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 58,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| April 17, June 9, and July 15, 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,484,880
|
|
|
9,484,880
|
9,484,880
|
|
|
|
|
| Gross proceeds from issuance of ordinary shares | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 479,000,000
|
|
|
|
|
|
|
|
|
| Transaction costs incurred | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
| Contingent options recognized as derivative liability | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 87,000,000
|
|
|
|
|
|
|
|
|
| December 15 and 29, 2017 | Convertible Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,554,960
|
|
|
6,554,960
|
6,554,960
|
|
|
|
|
| Debt principal amount | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 411,000,000
|
|
|
|
|
| Accrued interest | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 37,000,000
|
|
|
|
|
| Number of Ordinary Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued and fully paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
187,492,667
|
183,901,040
|
167,258,400
|
187,492,667
|
187,492,667
|
|
|
|
|
| Number of ordinary shares repurchased |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,679,156
|
6,427,271
|
|
|
|
|
|
|
|
| Other Paid in Capital | December 15 and 29, 2017 | Convertible Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Classes Of Share Capital [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible notes | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 1,100,000,000
|
|
|
|
|
|
|
|
|